Alectinib
Stock Status: In Stock
Login to view price
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Alectinib Product Information
Alectinib is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Alectinib. The product is supplied by Clearsynth under CAT No. CS-T-50375.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Alectinib
CAS No.
1256580-46-7
CAT No.
CS-T-50375
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C30H34N4O2
Molecular Weight
482.62
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Alectinib is supplied with detailed characterization data compliant with regulatory guideline. Alectinib can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Alectinib.
Overview
CH5424802 is a highly selective and potent anaplastic lymphoma kinase (ALK) inhibitor capable of blocking the resistant gatekeeper mutant, which results in reduced cell growth. CH5424802 have been clinically evaluated for the treatment of patients with ALK-driven tumors.
Synonyms
Alectinib
Application Notes
CH5424802 is a highly selective and potent anaplastic lymphoma kinase (ALK) inhibitor capable of blocking the resistant gatekeeper mutant, which results in reduced cell growth. CH5424802 have been clinically evaluated for the treatment of patients with ALK-driven tumors.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.